UK markets closed

Biofrontera AG (BFFTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.08000.0000 (0.00%)
As of 09:45AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 23.82M
Enterprise value 21.45M
Trailing P/E 132.97
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.39
Price/book (mrq)3.76
Enterprise value/revenue 0.75
Enterprise value/EBITDA -3.01

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-20.00%
S&P500 52-week change 323.57%
52-week high 31.3500
52-week low 31.0800
50-day moving average 31.0800
200-day moving average 31.0800

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 563.81M
Implied shares outstanding 663.81M
Float 810.05M
% held by insiders 167.60%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -1.14%
Operating margin (ttm)8.75%

Management effectiveness

Return on assets (ttm)9.42%
Return on equity (ttm)-1.83%

Income statement

Revenue (ttm)32.25M
Revenue per share (ttm)0.87
Quarterly revenue growth (yoy)94.50%
Gross profit (ttm)N/A
EBITDA 5.57M
Net income avi to common (ttm)-369k
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.08M
Total cash per share (mrq)0.08
Total debt (mrq)1.15M
Total debt/equity (mrq)5.74%
Current ratio (mrq)1.76
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)-1.91M
Levered free cash flow (ttm)-1.44M